Vitestro
PrivateLast Round
Series B
Mar 10, 2026
Total Funding Raised
$174.93M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vitestro operates in Healthcare & Life Sciences and is based in Utrecht. Its latest recorded funding round was a Series B round in March 2026.
Vitestro is a medical robotics company that develops and manufactures autonomous blood drawing devices for hospitals and clinical laboratories.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vitestro Comparables
Compare Vitestro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BHealthCare | 91% | |
| Loop Medical SA | 76% | |
| Veebot Systems Inc. | 75% |
For institutional investors. Book with your work email.
Vitestro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 10, 2026 | ||||
| Series A Extension | Apr 30, 2024 | ||||
| Series B | Mar 10, 2024 | ||||
| Series A | Mar 21, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vitestro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifeblood Capital | Series A Extension |
| InterVest | Series B |
| European Innovation Council Fund | Series A Extension, Series B |
| Puma Venture Capital | Series B |
| Invest-NL | Series A Extension, Series B |
| McPike Global Family Office | Series B |
| ROM Utrecht Region | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Job posting indicates funding extends through 2027.
- Jul 1, 2026
Medical device received CE Mark approval.
For institutional investors. Book with your work email.
Vitestro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vitestro's valuation, stock price, and market status.
Is Vitestro a public or private company?
Vitestro is a private company.
What is the current stock price of Vitestro?
Vitestro is a private company, so its shares have no public market price. Caplight tracks Vitestro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vitestro worth (valuation)?
Valuation information for Vitestro is not publicly available.
Can I buy Vitestro stock?
Vitestro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vitestro's last funding round?
Vitestro's most recent funding round was Series B on March 10, 2026.
Who are the main investors in Vitestro?
Key investors in Vitestro include Sonder Capital.
Will Vitestro IPO soon?
No public IPO plans have been announced for Vitestro.
How can I track Vitestro secondary market activity?
Caplight tracks bids, offers, and trades in Vitestro's shares on secondary markets.